Related Experiment Video
Updated: Apr 23, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Correlation between osteoporosis and cardiovascular disease
Delia Sprini1, Giovam Battista Rini1, Laura Di Stefano1
1Department of Internal Medicine, University of Palermo, Palermo, Italy.
Insights
Osteoporosis patients face higher cardiovascular disease risks due to shared biological pathways. Further research is crucial for understanding these links and developing new treatments for both conditions.
Area of Science:
- Cardiovascular Medicine
- Bone Biology
- Biochemistry
Background:
- Growing evidence suggests a correlation between osteoporosis and cardiovascular diseases (CVD).
- Osteoporosis patients exhibit an increased risk of developing CVD compared to individuals with normal bone density.
- Previous studies, often using heterogeneous approaches and diverse populations, have yielded findings with limited conclusive strength.
Purpose of the Study:
- To explore the complex relationship and shared mechanisms between osteoporosis and cardiovascular diseases.
- To investigate the role of specific proteins and pathways in both bone and vascular calcification.
- To highlight the need for further research to inform preventive and therapeutic strategies for both conditions.
Main Methods:
- Review of existing scientific literature and animal model studies.
- Analysis of the role of proteins such as BMP, osteopontin, and osteoprotegerin (OPG) in bone and vascular health.
- Examination of shared risk factors including oxidative stress, inflammation, and lipid metabolism.
Main Results:
- Vascular calcification mechanisms share similarities with bone calcification pathways.
- Proteins integral to bone health, like OPG, are also found in calcified vascular tissue and may protect against calcification.
- Elevated OPG levels are observed in patients with CVD, suggesting a potential link.
- Shared risk factors like oxidative stress and inflammation are implicated in both conditions.
- Osteoporosis medications demonstrate inhibitory effects on atherosclerotic processes.
Conclusions:
- The underlying mechanisms connecting osteoporosis and cardiovascular disease require further elucidation.
- Understanding these links could lead to novel preventive and therapeutic approaches for both osteoporosis and CVD.
- Targeting shared pathways may offer a dual benefit for patients with either condition.
Abstract:
Several evidences have shown in the last years a possible correlation between cardiovascular diseases and osteoporosis. Patients affected with osteoporosis, for example, have a higher risk of cardiovascular diseases than subjects with normal bone mass. However, the heterogeneous approaches and the different populations that have been studied so far have limited the strength of the findings. Studies conducted in animal models show that vascular calcification is a very complex mechanism that involves similar pathways described in the normal bone calcification. Proteins like BMP, osteopontin, osteoprotegerin play an important role at the bone level but are also highly expressed in the calcified vascular tissue. In particular, it seems that the OPG protect from vascular calcification and elevated levels have been found in patients with CVD. Other factors like oxidative stress, inflammation, free radicals, lipids metabolism are involved in this complex scenario. It is not a case that medications used for treating osteoporosis also inhibit the atherosclerotic process, acting on blood pressure and ventricular hypertrophy. Given the limited amount of available data, further studies are needed to elucidate the underlying mechanisms between osteoporosis and cardiovascular disease which may be important in the future also for preventive and therapeutic approaches of both conditions.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Coronary Artery Disease I: Introduction